EDGAR Filing Documents for 0001663577-17-000284

Form 8-K - Current report:

SEC Accession No. 0001663577-17-000284

Filing Date

2017-09-06

Accepted

2017-09-06 17:20:44

Documents

Period of Report

2017-08-28

Items

Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		mainbody.htm	8-K	14097
2		ex99_1.htm	EX-99.1	28316
3	GRAPHIC	image_030.jpg	GRAPHIC	21557
4	GRAPHIC	image_012.jpg	GRAPHIC	73524
5	GRAPHIC	image_013.jpg	GRAPHIC	43582
6	GRAPHIC	image_014.jpg	GRAPHIC	61315
7	GRAPHIC	image_015.jpg	GRAPHIC	60805
8	GRAPHIC	image_016.jpg	GRAPHIC	41783
9	GRAPHIC	image_017.jpg	GRAPHIC	40885
10	GRAPHIC	image_018.jpg	GRAPHIC	46904
11	GRAPHIC	image_019.jpg	GRAPHIC	68382
12	GRAPHIC	image_020.jpg	GRAPHIC	64582
13	GRAPHIC	image_021.jpg	GRAPHIC	38535
14	GRAPHIC	image_022.jpg	GRAPHIC	41610
15	GRAPHIC	image_023.jpg	GRAPHIC	40583
16	GRAPHIC	image_024.jpg	GRAPHIC	49835
17	GRAPHIC	image_025.jpg	GRAPHIC	71438
18	GRAPHIC	image_026.jpg	GRAPHIC	48553
19	GRAPHIC	image_027.jpg	GRAPHIC	57124
20	GRAPHIC	image_028.jpg	GRAPHIC	62494
21	GRAPHIC	image_029.jpg	GRAPHIC	27131
	Complete submission text file	0001663577-17-000284.txt		1369146

Mailing Address 244, 5TH AVENUE, SUITE A154 NEW YORK NY 10001

Business Address 244, 5TH AVENUE, SUITE A154 NEW YORK NY 10001 (646) 453-4912

Blake Insomnia Therapeutics, Inc. (Filer) CIK: 0001556416 (see all company filings)